Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Bone Morphogenetic Protein Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Bone Morphogenetic Protein Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 rhBMP-2
      • 1.3.3 rhBMP-7
    • 1.4 Market Segment by Application
      • 1.4.1 Global Bone Morphogenetic Protein Market Share by Application (2019-2025)
      • 1.4.2 Spinal Fusion
      • 1.4.3 Trauma
      • 1.4.4 Reconstruction
      • 1.4.5 Oral Maxillofacial
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Bone Morphogenetic Protein Production Value 2014-2025
      • 2.1.2 Global Bone Morphogenetic Protein Production 2014-2025
      • 2.1.3 Global Bone Morphogenetic Protein Capacity 2014-2025
      • 2.1.4 Global Bone Morphogenetic Protein Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Bone Morphogenetic Protein Market Size CAGR of Key Regions
      • 2.2.2 Global Bone Morphogenetic Protein Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Bone Morphogenetic Protein Capacity by Manufacturers
      • 3.1.2 Global Bone Morphogenetic Protein Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Bone Morphogenetic Protein Revenue by Manufacturers (2014-2019)
      • 3.2.2 Bone Morphogenetic Protein Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Bone Morphogenetic Protein Market Concentration Ratio (CR5 and HHI)
    • 3.3 Bone Morphogenetic Protein Price by Manufacturers
    • 3.4 Key Manufacturers Bone Morphogenetic Protein Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Bone Morphogenetic Protein Market
    • 3.6 Key Manufacturers Bone Morphogenetic Protein Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 rhBMP-2 Production and Production Value (2014-2019)
      • 4.1.2 rhBMP-7 Production and Production Value (2014-2019)
    • 4.2 Global Bone Morphogenetic Protein Production Market Share by Type
    • 4.3 Global Bone Morphogenetic Protein Production Value Market Share by Type
    • 4.4 Bone Morphogenetic Protein Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Bone Morphogenetic Protein Consumption by Application

    6 Production by Regions

    • 6.1 Global Bone Morphogenetic Protein Production (History Data) by Regions 2014-2019
    • 6.2 Global Bone Morphogenetic Protein Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Bone Morphogenetic Protein Production Growth Rate 2014-2019
      • 6.3.2 United States Bone Morphogenetic Protein Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Bone Morphogenetic Protein Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Bone Morphogenetic Protein Production Growth Rate 2014-2019
      • 6.4.2 European Union Bone Morphogenetic Protein Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Bone Morphogenetic Protein Import & Export
    • 6.5 China
      • 6.5.1 China Bone Morphogenetic Protein Production Growth Rate 2014-2019
      • 6.5.2 China Bone Morphogenetic Protein Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Bone Morphogenetic Protein Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Bone Morphogenetic Protein Consumption by Regions

    • 7.1 Global Bone Morphogenetic Protein Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Bone Morphogenetic Protein Consumption by Type
      • 7.2.2 United States Bone Morphogenetic Protein Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Bone Morphogenetic Protein Consumption by Type
      • 7.3.2 European Union Bone Morphogenetic Protein Consumption by Application
    • 7.4 China
      • 7.4.1 China Bone Morphogenetic Protein Consumption by Type
      • 7.4.2 China Bone Morphogenetic Protein Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Bone Morphogenetic Protein Consumption by Type
      • 7.5.2 Rest of World Bone Morphogenetic Protein Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Fidia
      • 8.1.1 Fidia Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Bone Morphogenetic Protein
      • 8.1.4 Bone Morphogenetic Protein Product Introduction
      • 8.1.5 Fidia Recent Development
    • 8.2 Medtronic
      • 8.2.1 Medtronic Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Bone Morphogenetic Protein
      • 8.2.4 Bone Morphogenetic Protein Product Introduction
      • 8.2.5 Medtronic Recent Development
    • 8.3 TRB Chemedica
      • 8.3.1 TRB Chemedica Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Bone Morphogenetic Protein
      • 8.3.4 Bone Morphogenetic Protein Product Introduction
      • 8.3.5 TRB Chemedica Recent Development
    • 8.4 Meda Pharma
      • 8.4.1 Meda Pharma Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Bone Morphogenetic Protein
      • 8.4.4 Bone Morphogenetic Protein Product Introduction
      • 8.4.5 Meda Pharma Recent Development
    • 8.5 Sanofi Genzyme
      • 8.5.1 Sanofi Genzyme Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Bone Morphogenetic Protein
      • 8.5.4 Bone Morphogenetic Protein Product Introduction
      • 8.5.5 Sanofi Genzyme Recent Development
    • 8.6 Depuy Synthes
      • 8.6.1 Depuy Synthes Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Bone Morphogenetic Protein
      • 8.6.4 Bone Morphogenetic Protein Product Introduction
      • 8.6.5 Depuy Synthes Recent Development
    • 8.7 Bioventus
      • 8.7.1 Bioventus Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Bone Morphogenetic Protein
      • 8.7.4 Bone Morphogenetic Protein Product Introduction
      • 8.7.5 Bioventus Recent Development
    • 8.8 Laboratoire Genevrier
      • 8.8.1 Laboratoire Genevrier Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Bone Morphogenetic Protein
      • 8.8.4 Bone Morphogenetic Protein Product Introduction
      • 8.8.5 Laboratoire Genevrier Recent Development
    • 8.9 Recordati
      • 8.9.1 Recordati Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Bone Morphogenetic Protein
      • 8.9.4 Bone Morphogenetic Protein Product Introduction
      • 8.9.5 Recordati Recent Development
    • 8.10 Stryker
      • 8.10.1 Stryker Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Bone Morphogenetic Protein
      • 8.10.4 Bone Morphogenetic Protein Product Introduction
      • 8.10.5 Stryker Recent Development
    • 8.11 RTI Biologics
    • 8.12 Croma-Pharma
    • 8.13 Zimmer Biomet

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Bone Morphogenetic Protein Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Bone Morphogenetic Protein Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Bone Morphogenetic Protein Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Bone Morphogenetic Protein Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Bone Morphogenetic Protein Production Forecast by Type
      • 9.7.2 Global Bone Morphogenetic Protein Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Bone Morphogenetic Protein Sales Channels
      • 10.2.2 Bone Morphogenetic Protein Distributors
    • 10.3 Bone Morphogenetic Protein Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Bone morphogenetic proteins (BMPs) are growth factors that induce the formation of bone after a fracture. In nature, these proteins have a critical role during embryonic development in the formation of the skeleton.
      In 2019, the market size of Bone Morphogenetic Protein is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bone Morphogenetic Protein.

      This report studies the global market size of Bone Morphogenetic Protein, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Bone Morphogenetic Protein production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Fidia
      Medtronic
      TRB Chemedica
      Meda Pharma
      Sanofi Genzyme
      Depuy Synthes
      Bioventus
      Laboratoire Genevrier
      Recordati
      Stryker
      RTI Biologics
      Croma-Pharma
      Zimmer Biomet

      Market Segment by Product Type
      rhBMP-2
      rhBMP-7

      Market Segment by Application
      Spinal Fusion
      Trauma
      Reconstruction
      Oral Maxillofacial

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Bone Morphogenetic Protein status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Bone Morphogenetic Protein manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Bone Morphogenetic Protein are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now